Placeholder Banner

Comments to FDA on the Agency’s Information Technology Strategy

October 30, 2023

BIO and PhRMA submitted joint comments on the U.S. Food and Drug Administration’s Information Technology Strategy (Docket No. FDA-2023-N-3636)

Download Full Comments Below
FINAL_PhRMA BIO Comments_FDA IT Strategy_2023-10-30
Discover More
BIO provided general comments and recommended edits Re: FDA-2023-D-3031
BIO joins 30 other national trade associations in speaking out against unprecedented and burdensome FTC-DOJ regulation of mergers
BIO submits comments in response to the agency’s request for information (FDA-2023-N-3742)